BioCentury
ARTICLE | Company News

Alector debuts with A round, license to Adimab tech

November 1, 2013 1:02 AM UTC

Alector LLC (San Francisco, Calif.) debuted on Thursday with a non-exclusive license to yeast-based antibody discovery technology from Adimab LLC (Lebanon, N.H.) and undisclosed funding from Polaris V...